FindTrial
Sign In

The comparison of two intensive care unit scoring systems, APACHE II and APACHE IV to predict mortality in sepsis patients in an intensive care unit in a tertiary care hospital

The comparison of APACHE II and APACHE IV score to predict mortality in sepsis patients in an intensive care unit in a tertiary care hospital - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055510
Enrollment
98
Registered
2023-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

MS Ramaiah Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted to the Intensive Care Unit and who are diagnosed with sepsis

Exclusion criteria

Exclusion criteria: 1. Patients admitted with burns 2. Patients admitted with head injury 3. Patients on chemotherapy, or known cases of malignancy, 4. Patients admitted following cardiac arrest 5. Pregnant patients

Design outcomes

Primary

MeasureTime frame
To compare the ability of APACHE II & APACHE IV in predicting mortality in ICU patients suffering from sepsis, where survivors are taken as patients who are discharged from the ICU & non survivors are taken as patients who die in the ICUTimepoint: Discharge from the ICU or death in the ICU—

Secondary

MeasureTime frame
To determine the correlation between APACHE II & APACHE IV with length of stay in the ICUTimepoint: Number of days between admission & discharge from the ICU—

Countries

India

Contacts

Public ContactDr Rooparani K

MS Ramaiah Medical College

drrooparani@gmail.com9686709000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026